RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q4 2023 · 260 positions · Total reported value $1.73B · Top-10 concentration 25.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 260 equity positions with a combined reported value of $1.73B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 25.4% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q4 2023 were DFIN ($59.16M), LRN ($56.21M), WNS ($46.04M). By sector, the heaviest allocations are Consumer Discretionary 24.2%, Health Care 24.1%. Versus the prior quarter, allocation shifted toward Health Care (+1.1pp), Financials (+0.8pp) and away from Consumer Discretionary (-1.1pp), Other (-1.4pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 93% of names.

The largest new positions opened in Q4 2023 were ADUS ($3.75M), VITL ($3.22M), GMED ($2.47M).

Of the 12 positions fully exited versus the prior quarter, the largest were NXGN ($9.14M), DEN ($3.51M), XPOF ($1.60M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • ADUS ADDUS HOMECARE CORP · $3.75M
  • VITL VITAL FARMS INC · $3.22M
  • GMED GLOBUS MED INC · $2.47M
  • FOUR SHIFT4 PMTS INC · $2.24M
  • RPAY REPAY HLDGS CORP · $2.14M
  • LINC LINCOLN EDL SVCS CORP · $2.01M
  • IWC iShares Russell Micro-Cap ETF · $1.62M
  • IWM ISHARES TR · $1.57M

Fully Exited (vs previous quarter)

  • NXGN NEXTGEN HEALTHCARE INC · prev qtr: $9.14M
  • DEN DENBURY INC · prev qtr: $3.51M
  • XPOF XPONENTIAL FITNESS INC · prev qtr: $1.60M
  • CALY CALLAWAY GOLF CO · prev qtr: $1.55M
  • SHYF SHYFT GROUP INC · prev qtr: $1.25M
  • ABCM ABCAM PLC · prev qtr: $843.35K
  • AAP ADVANCE AUTO PARTS INC · prev qtr: $783.75K
  • TTD THE TRADE DESK INC · prev qtr: $758.91K

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 24.1%
Technology 12.9%
Financials 7.4%
Other 18.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 948.47K $59.16M 3.43%
3.43%
Reduce
2 946.81K $56.21M 3.25%
3.25%
Reduce
3 728.47K $46.04M 2.67%
2.67%
Add
4 1.46M $44.79M 2.59%
2.59%
Hold
5 484.75K $41.04M 2.38%
2.38%
Hold
6 666.61K $40.81M 2.36%
2.36%
Add
7 390.65K $39.65M 2.30%
2.30%
Reduce
8 127.64K $39.13M 2.27%
2.27%
Reduce
9 450.58K $36.76M 2.13%
2.13%
Hold
10 1.04M $34.95M 2.02%
2.02%
Add
11 3.64M $34.65M 2.01%
2.01%
Add
12 163.18K $31.20M 1.81%
1.81%
Reduce
13 428.48K $28.79M 1.67%
1.67%
Reduce
14 302.09K $26.46M 1.53%
1.53%
Hold
15 623.35K $25.37M 1.47%
1.47%
Reduce
16 457.69K $24.99M 1.45%
1.45%
Reduce
17 239.40K $23.54M 1.36%
1.36%
Hold
18 533.84K $23.24M 1.35%
1.35%
Add
19 692.85K $21.69M 1.26%
1.26%
Hold
20 168.88K $21.27M 1.23%
1.23%
Reduce
21 744.02K $20.86M 1.21%
1.21%
Reduce
22 276.01K $19.71M 1.14%
1.14%
Reduce
23 750.91K $19.44M 1.13%
1.13%
Add
24 396.07K $18.70M 1.08%
1.08%
Reduce
25 359.64K $17.92M 1.04%
1.04%
Reduce
26 131.62K $17.34M 1.00%
1.00%
Hold
27 42.95K $17.12M 0.99%
0.99%
Reduce
28 350.49K $16.92M 0.98%
0.98%
Reduce
29 2.71M $16.74M 0.97%
0.97%
Reduce
30 198.27K $16.63M 0.96%
0.96%
Hold
31 50.17K $15.88M 0.92%
0.92%
Add
32 125.44K $15.77M 0.91%
0.91%
Reduce
33 1.85M $15.50M 0.90%
0.90%
Add
34 529.95K $15.34M 0.89%
0.89%
Reduce
35 913.99K $15.25M 0.88%
0.88%
Reduce
36 1.07M $15.13M 0.88%
0.88%
Reduce
37 68.92K $14.71M 0.85%
0.85%
Reduce
38 1.75M $14.23M 0.82%
0.82%
Add
39 201.06K $13.45M 0.78%
0.78%
Reduce
40 108.97K $13.41M 0.78%
0.78%
Hold
41 232.24K $13.18M 0.76%
0.76%
Reduce
42 2.20M $13.16M 0.76%
0.76%
Reduce
43 1.73M $11.87M 0.69%
0.69%
Reduce
44 636.03K $11.16M 0.65%
0.65%
Reduce
45 457.13K $10.38M 0.60%
0.60%
Reduce
46 1.02M $10.17M 0.59%
0.59%
Reduce
47 906.20K $9.54M 0.55%
0.55%
Reduce
48 243.98K $9.46M 0.55%
0.55%
Reduce
49 468.93K $9.32M 0.54%
0.54%
Add
50 580.49K $9.16M 0.53%
0.53%
Reduce

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 260 equity positions worth $1.73B in aggregate; its largest disclosed positions were DFIN ($59.16M), LRN ($56.21M), WNS ($46.04M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.73B of long equity holdings across 260 positions as of 2023-Q4. Top-10 holdings account for 25.4% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →